Levophacetoperane
Подписчиков: 0, рейтинг: 0
| Clinical data | |
|---|---|
| Routes of administration |
Oral |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C14H19NO2 |
| Molar mass | 233.311 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Levophacetoperane (Lidépran, Phacétoperane) is a psychostimulant developed by Rhône-Poulenc in the 1950s. The drug has been used as an antidepressant and anorectic. It is the reverse ester of methylphenidate.
See also
| |||||||||||||||||||||
| |||||||||||||||||||||
|
| |||||||||||||||||||||
| |||||||||||||||||||||
| |||||||||||||||||||||
| Central |
|
||||||
|---|---|---|---|---|---|---|---|
| Peripheral | |||||||
| |||||||
|
DAT (DRIs) |
|
||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NET (NRIs) |
|
||||||||||||||
|
SERT (SRIs) |
|
||||||||||||||
| VMATs | |||||||||||||||
| Others |
|
||||||||||||||